These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23827113)

  • 1. [Effect of Nrf2 and TrxR on proliferation of chronic myeloid leukemia cell and its mechanism].
    Pan F; Xu LR; Wang HW; Zhu MX; Liu Y; Tan YH; Chen XH; Ren FG
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):527-31. PubMed ID: 23827113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells].
    Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCR/ABL mRNA targeting small interfering RNA effects on proliferation and apoptosis in chronic myeloid leukemia.
    Zhu XS; Lin ZY; Du J; Cao GX; Liu G
    Asian Pac J Cancer Prev; 2014; 15(12):4773-80. PubMed ID: 24998540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the Nrf2-TrxR Axis Sensitizes the Drug-Resistant Chronic Myelogenous Leukemia Cell Line K562/G01 to Imatinib Treatments.
    Xu L; Zhao Y; Pan F; Zhu M; Yao L; Liu Y; Feng J; Xiong J; Chen X; Ren F; Tan Y; Wang H
    Biomed Res Int; 2019; 2019():6502793. PubMed ID: 31828114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
    Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of specific siRNA targeting at bcr-abl fusion gene and its combination with p27 gene clone on chronic myeloid leukemia cell line K562].
    Wang W; DU Y; Lin GQ; Li NN; Sun BZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):606-11. PubMed ID: 20561411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of up-regulated expression of tumor suppressor gene p14(ARF) on apoptosis of chronic myeloid leukemia cells].
    Bai YS; Liu J; Liu XH; Dai EY; Sun BT; Lu ZX
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):512-5. PubMed ID: 23827110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitory effect of RNA interference on chronic myeloid leukemia bcr/abl oncogene expression].
    Ma XX; Wang C; Wei J; Qin YW; Yan SK; Gao YR; Cai Q
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):359-62. PubMed ID: 16185484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptotic effect of As2S2 on K562 cells and its mechanism.
    Li JE; Wu WL; Wang ZY; Sun GL
    Acta Pharmacol Sin; 2002 Nov; 23(11):991-6. PubMed ID: 12421474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental study of K562 cell apoptosis induced by siRNA].
    Chen BB; Fan HH; Lin GW; Yuan ZH; Lu HZ; Gao L; Liu Y
    Zhonghua Xue Ye Xue Za Zhi; 2004 Dec; 25(12):717-9. PubMed ID: 15730712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of apoptosis induced by indomethacin in chronic myeloid leukemia].
    Tu C; Zhang G; Lu H
    Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):362-5. PubMed ID: 11721434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulation of wild type PTEN gene on Survivin, Xiap and Smac in chronic leukemia cells].
    Cheng ZY; Wan JS; Wang YL; Liang LQ; Liang WT; Mu J; Lu X; Pan L
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(40):2868-72. PubMed ID: 22333553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Construction of retrovirus vector of bcr/abl mRNA cleaving ribozyme gene and its effects on K562 cells].
    Wu Y; Chen Y; Hu J
    Zhonghua Xue Ye Xue Za Zhi; 1998 Dec; 19(12):623-6. PubMed ID: 11263328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The mechanism of apoptosis of chronic myeloid leukemia cells induced by the novel p210 bcr/abl inhibitor berbamine].
    Sun JR; Zhang XH; He ZW; Gu Y; Yu YZ; Fang YM; Lü QH; Dong QH; Xu RZ
    Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2246-51. PubMed ID: 17064567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction of Eukaryotic Expression Vector of siRNA Specific for BCR/ABL Fusion Gene and Its Effects on K562 Cells].
    Li M; Wang BL; Wang LN; Xi YM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1698-1704. PubMed ID: 28024479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-152-3p promotes the development of chronic myeloid leukemia by inhibiting p27.
    Wang L; Wang Y; Lin J
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8789-8796. PubMed ID: 30575920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS; Liu DS; Dai CW; Li RJ
    Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Knockdown of Hsp701A induces K562 cells apoptosis by RNA interference].
    Zhu Q; Zhang WG; Wang LF; Wang F; Zhang Y; Yang AG
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):480-2, 484. PubMed ID: 16806014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells.
    Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
    Exp Cell Res; 2009 Jul; 315(11):1809-18. PubMed ID: 19268463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additive antileukemia effects by GFI1B- and BCR-ABL-specific siRNA in advanced phase chronic myeloid leukemic cells.
    Koldehoff M; Zakrzewski JL; Beelen DW; Elmaagacli AH
    Cancer Gene Ther; 2013 Jul; 20(7):421-7. PubMed ID: 23788109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.